跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AGAMREE 40 MG/ML SUSPENSION ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AGAMREE 40 MG/ML SUSPENSION ORAL
Approved
STANDARD
AGAMREE 40 MG/ML SUSPENSION ORAL
Santhera Pharmaceuticals Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 9, 2024
Approval ID
3d59b6bfbf8bfedd
Company
Santhera Pharmaceuticals Gmbh
Type
Standard
Approval Details
Approval Id
3d59b6bfbf8bfedd
Drug Cima Aemps Name
AGAMREE 40 MG/ML SUSPENSION ORAL
Register Number
1231776001
Holder Company Name
Santhera Pharmaceuticals Gmbh
Marketing Company Name
Santhera Pharmaceuticals (Spain) S.L.
Authorization Date
2024-05-09
Dosage Form
SUSPENSIÓN ORAL
Dose
40 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Santhera Pharmaceuticals Gmbh
Active Ingredients
VAMOROLONA
4000 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 9, 2024
Approval ID
3d59b6bfbf8bfedd
Type
Standard
Back to CIMA-AEMPS Approvals